Lysosomal degradation of cytoplasmic components by autophagy is essential for cellular survival and homeostasis under nutrient-deprived conditions1–4. Acute regulation of autophagy by nutrient-sensing kinases is well defined3, 5–7, but longer-term transcriptional regulation is relatively unknown. Here we show that the fed-state sensing nuclear receptor FXR8, 9 and the fasting transcriptional activator CREB10, 11 coordinately regulate the hepatic autophagy gene network. Pharmacological activation of FXR repressed many autophagy genes and inhibited autophagy even in fasted mice and feeding-mediated inhibition of macroautophagy was attenuated in FXR-knockout mice. From mouse liver ChIP-seq data12–15, FXR and CREB binding peaks were detected at 178 and 112, respectively, of 230 autophagy-related genes, and 78 genes showed shared binding, mostly in their promoter regions. CREB promoted lipophagy, autophagic degradation of lipids16, under nutrient-deprived conditions, and FXR inhibited this response. Mechanistically, CREB upregulated autophagy genes, including Atg7, Ulk1, and Tfeb, by recruiting the coactivator CRTC2. After feeding or pharmacological activation, FXR trans-repressed these genes by disrupting the functional CREB/CRTC2 complex. This study identifies the novel FXR/CREB axis as a key physiological switch regulating autophagy, resulting in sustained nutrient regulation of autophagy during feeding/fasting cycles.
Background: Current descriptions of steroid hormone action are largely phenomenological rather than mechanistic. Results: Methodology is described for determining kinetically defined mechanisms and relative sites of action of any two cofactors with steroid receptors. Conclusion: Position and mode of reporter gene action are constant. Significance: Location and mechanistic action of cofactors, relative to each other and reporter, is assignable in sequence for receptor-regulated gene transactivation.
Background: Understanding glucocorticoid receptor (GR)-regulated gene transcription requires detailed description of cofactor actions. Results: NELF subunits have new activities altering GR induction properties of exogenous and endogenous genes. Conclusion: NELF-A and NELF-B are decelerators functioning at two positions after GR and before/at the reporter gene site of action. Significance: Functional ordering of NELF-A and NELF-B relative to other factors in GR transactivation is determined.
A gene induction
competition assay has recently uncovered new inhibitory
activities of two transcriptional cofactors, NELF-A and NELF-B, in
glucocorticoid-regulated transactivation. NELF-A and -B are also components
of the NELF complex, which participates in RNA polymerase II pausing
shortly after the initiation of gene transcription. We therefore asked
if cofactors (Cdk9 and ELL) best known to affect paused polymerase
could reverse the effects of NELF-A and -B. Unexpectedly, Cdk9 and
ELL augmented, rather than prevented, the effects of NELF-A and -B.
Furthermore, Cdk9 actions are not blocked either by Ckd9 inhibitors
(DRB or flavopiridol) or by two Cdk9 mutants defective in kinase activity.
The mode and site of action of NELF-A and -B mutants with an altered
NELF domain are similarly affected by wild-type and kinase-dead Cdk9.
We conclude that Cdk9 is a new modulator of GR action, that Ckd9 and
ELL have novel activities in GR-regulated gene expression, that NELF-A
and -B can act separately from the NELF complex, and that Cdk9 possesses
activities that are independent of Cdk9 kinase activity. Finally,
the competition assay has succeeded in ordering the site of action
of several cofactors of GR transactivation. Extension of this methodology
should be helpful in determining the site and mode of action of numerous
additional cofactors and in reducing unwanted side effects.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.